Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Immense financial pressures, like declining reimbursements and a shift from inpatient to outpatient services, are forcing hospitals and health systems to accelerate efforts around driving cost efficiencies.
Here are the three latest drugs or medical devices approved by the FDA this week.
Amazon discretely launched Basic Care, an exclusive line of 60 over-the-counter healthcare products, last August and consumers are finding the products to be priced comparably, if not cheaper, to generic products retailed at other well-known pharmacies, according to Business Insider.
Achillion Pharmaceuticals, a clinical stage drugmaker based in New Haven, Conn., will slash its workforce by 20 percent to help offset an $85.2 million loss in fiscal year 2017.
As disruptors continue to push into the healthcare arena and pressure accumulates to reduce drug prices, pharmaceutical companies are taking steps to remain competitive and enhance their drug pipelines.
In a move to expand its cancer immunotherapy pipeline, Merck & Co. inked a deal Wednesday to buy Viralytics, a virus-based cancer drug firm, for 502 million Australian dollars ($394 million), according to Reuters.
Cook Medical, a Bloomington, Ind.-based medical device company, revealed Tuesday it is realigning its global workforce to adapt to today's healthcare needs.
Medtronic CEO Omar Ishrak, PhD, is taking the medical device company in a slightly different direction: accepting more risk in how it gets paid for its products, according to The Wall Street Journal.
Republican Arkansas Governor Asa Hutchinson plans to hold a special legislative session to discuss low reimbursement rates pharmacies receive from pharmacy benefit managers, reports Arkansas Times.
The FDA granted expanded approval for Stryker's Trevo Retriever device Feb. 15.